TickerGuard
Buy Day today: Neutral (48) Mixed market breadth · no major macro event
RNXT

RenovoRx Inc

Healthcare · Biotechnology

1.60$ -6.6% vs. previous close Closing price · As of: Sep 28, 2026

Statements

Balance Sheet

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Balance Sheet RNXT
Line item 2019 2020 2021 2022 2023 2024 2025
– -15.7% +750.9% -55.4% -79.8% +453.8% -0.3%
– -15.7% +752.4% -55.4% -79.8% +434.0% +0.8%
– -14.7% +746.4% -71.1% -73.3% +509.9% -1.8%
– -14.7% +746.4% -57.6% -81.8% +509.9% -1.8%
– – – – – – +223.3%
– – – – – – –
– – – – – – –
– +1,958.4% -94.3% +17.5% +305.3% -18.5% -26.6%
– +408.8% -77.1% +17.5% +6.6% +62.5% +2.8%
– – – – – – +59.1%
– -69.9% +224.1% +1.7% +5.1% +4.5% +36.3%
– – – – – – –
– -1,100.4% – -59.8% -148.7% – +21.1%
– – – – – – –
– +0.0% +3.1% +1.3% +13.7% +14.7% +49.7%

Data as of: September 28, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?